Kmds.Jk

The company maintains a strong liquidity position, with a current ratio of 3.6, indicating a robust ability to meet short-term obligations. Its liquidity_fpt score of 0.94 suggests that the company is well-positioned to manage its cash flow and short-term liabilities without significant risk. The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, which implies a conservative approach to financing and a strong equity base. This low leverage is further supported by a total long-term debt of only 1.53 billion IDR, compared to total equity of 258.3 billion IDR.

In terms of profitability, the company demonstrates a return on equity (ROE) of 21.63% and a return on assets (ROA) of 18.01%, both of which are well above the industry median for the Non-Alcoholic Beverages sector. The operating margin, calculated as operating income of 63.72 billion IDR on revenue of 427.81 billion IDR, is 14.9%, which is a strong indicator of efficient cost management and pricing power. The net profit margin of 13.06% (55.87 billion IDR net income on 427.81 billion IDR revenue) further underscores the company's profitability.

The company's revenue is primarily concentrated in Indonesia, with no significant international operations disclosed in the available data. The business is segmented into pharmaceuticals, nutraceuticals, and functional foods, with no specific revenue breakdown provided in the latest financial data. However, the company's extensive distribution network and brand recognition in the Indonesian market suggest a strong domestic presence.

Looking ahead, the company is projected to maintain a stable growth trajectory, with revenue expected to increase by 5.2% in the current fiscal year and 4.8% in the following year. This growth is supported by the company's strong market position and the continued demand for health and wellness products in Indonesia. The company's capital expenditure of -8.8 billion IDR indicates a focus on cost optimization and efficient use of capital.

The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based flags detected. The dilution potential is also low, with no significant share issuance or dilution events reported in the latest filings. The company's conservative capital structure and strong liquidity position further mitigate financial risk.

Recent events, including the latest financial filings and transcripts, indicate a stable business environment for the company. The company has not reported any significant operational or financial disruptions in the latest quarters, and its strategic focus remains on maintaining market leadership and expanding its product portfolio.